Innovative Study Shows Promising Results of Onabotulinum Toxin-A Injection for Trigeminal Neuralgia

Posted: December 2, 2024
A recent prospective observational study investigated the efficacy and safety of Onabotulinum toxin-A injection at the sphenopalatine ganglion for trigeminal neuralgia. The study revealed a significant reduction in pain intensity and frequency of pain attacks in patients who were unresponsive to or intolerant of oral medication. Complications such as hemifacial palsy and diplopia were noted but resolved within three months. The findings suggest that this approach is effective for trigeminal neuralgia patients who struggle with medication side effects or treatment resistance.

This article summary was generated by AI. To view the full article, click the link here: https://pubmed.ncbi.nlm.nih.gov/39623300/
Views: 1
Sponsors
Townie Perks
Townie® Poll
Who or what do you turn to for most financial advice regarding your practice?
  
The Dentaltown Team, Farran Media Support
Phone: +1-480-445-9710
Email: support@farranmedia.com
©2025 Dentaltown, a division of Farran Media • All Rights Reserved
9633 S. 48th Street Suite 200 • Phoenix, AZ 85044 • Phone:+1-480-598-0001 • Fax:+1-480-598-3450